Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin

References

• Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Issacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–6
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267–71
   PubMed Web of Science ®Google Scholar
• Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–4
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7
   PubMed Web of Science ®Google Scholar
• Weber DM, Dimopoulos MA, Anandu DP, Pugh WC, Steinbach G. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 1994; 107: 1835–8
   PubMed Web of Science ®Google Scholar
• Montalban C, Manzanal A, Boixeda D, Redondo C, Bellas C. Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Lancet 1995; 345: 798–9
   PubMed Web of Science ®Google Scholar
• Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345: 1591–4
   PubMed Web of Science ®Google Scholar
• Nagashima R, Takeda H, Maeda K, Ohno S, Takahashi T. Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterology 1996; 111: 1674
   PubMed Web of Science ®Google Scholar
• Oiya H, Okawa K, Noguchi A, Kouno M, Aomatsu K, Yamasaki T, et al. Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication in a patient negative for Helicobacter pylori. Jpn J Gastroenterol Endosc 2003; 45: 965–69
   Google Scholar
• Matsumoto T, Iida M, Shimizu M. Regression of mucosa-associated lymphoid tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 1997; 350: 115–6
   PubMed Web of Science ®Google Scholar
• Nebiki H, Harihara S, Tsukuda H, Inoue T, Arakawa T. Regression of gastric MALT lymphoma after unsuccessful anti-H. pylori therapy. Am J Gastroenterol 2000; 95: 3684–6
   PubMed Web of Science ®Google Scholar
• Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998; 157: 1829–32
   PubMed Web of Science ®Google Scholar
• Itkin IH, Nenzel MI. The use of macrolide antibiotic substances in the treatment of asthma. J Allergy 1970; 45: 146
   PubMedGoogle Scholar
• Kim JS, Jung HC, Shin KH, Song IS, Kim CY. Eradication of Helicobacter pylori infection did not lead to cure of duodenal mucosa-associated lymphoid tissue lymphoma. Scand J Gastroenterol 1999; 34: 215–8
   PubMed Web of Science ®Google Scholar
• Issacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410–6
   PubMed Web of Science ®Google Scholar
• Oshima C, Okazaki K, Matsushima Y, Sawada M, Chiba T, Takahashi K, et al. Helicobacter infection in Balb/c mice with postthymectomy autoimmune gastritis: induction of follicular gastritis in the corpus. Infect Immun 2000; 68: 100–6
   PubMed Web of Science ®Google Scholar
• Uchida K, Okazaki K, Debrecceni A, Nishi T, Iwano H, Inai M, et al. Analysis of cytokines in the early development of gastric secondary lymphoid follicles in Helicobacter pylori-infected Balb/c mice with neonatal thymectomy. Infect Immun 2001; 69: 6749–54
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nakamura S, Yonezumi M, Suzuki T, Matsuura A, Yatabe Y, et al. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 2000; 91: 301–9
   PubMedGoogle Scholar
• Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001; 48: 454–60
   PubMed Web of Science ®Google Scholar
• Kawasaki S, Takizawa H, Ohtoshi T, Takeuchi N, Kohyama T, Nakamura H, et al. Roxithromycin inhibits cytokine production by and neurophil attachment to human bronchial epithelial cells in vitro. Antimicrob Agents Chemother 1998; 42: 1499–502
   PubMed Web of Science ®Google Scholar
• Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin. Int Arch Allergy Immunol 1994; 105: 308–16
   PubMed Web of Science ®Google Scholar
• Suzaki H, Asano K, Ohki S, Kanai K, Mizutani T, Hisamitsu T. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo. Mediators Inflamm 1999; 8: 199–204
   PubMed Web of Science ®Google Scholar
• Khan AA, Slifer TR, Araujo FG, Remington JS. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 1999; 11: 121–32
   PubMed Web of Science ®Google Scholar
• Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153–9
   PubMed Web of Science ®Google Scholar
• Takizawa H, Desaki M, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 156: 266–71
   PubMed Web of Science ®Google Scholar
• Mukae H, Kadota J, Kohno S, Kusano S, Morikawa T, Matsukura S, et al. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1995; 152: 613–8
   PubMed Web of Science ®Google Scholar
• Kawakami K, Kadota J, Iida K, Fujii T, Shirai R, Matsubara Y, et al. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells. Clin Exp Immunol 1997; 107: 410–6
   PubMed Web of Science ®Google Scholar
• Shibata Y, Niwa M, Sone S, Nagayama S, Uesaka Y, Miura I. Primary malignant lymphoma of duodenum. Hepato-Gastroenterology 1998; 45: 2171–4
   PubMedGoogle Scholar
• Ventrucci M, Gherlinzoni F, Sabattini E, Cipolla A, Ubalducci GM, Pileri S. Primary MALT-lymphoma of the papilla of Vater. Dig Dis Sci 1998; 43: 214–6
   PubMed Web of Science ®Google Scholar
• Toshima M, Aikawa K, Soga K, Shibasaki K, Yoshida K, Emura I. Primary duodenal MALT lymphoma. Internal Med 1999; 38: 957–61
   PubMed Web of Science ®Google Scholar
• Xiang Z, Onoda N, Ohira M, Yukawa T, Uchida T, Arakawa T, et al. Mucosa-associated lymphoid tissue lymphoma of the duodenum: report of a case resistant to Helicobacter pylori eradication. Hepato-Gastroenterology 2004; 51: 732–5
   PubMedGoogle Scholar
• Nakase H, Okazaki K, Ohana M, Ikeda K, Uchida K, Uose S, et al. The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients. Endoscopy 2002; 34: 343–6
   PubMed Web of Science ®Google Scholar